Association between Parkinson’s Disease and Atrial Fibrillation: A Literature Review
Objective: Our literature review aims to summarize what has been reported in the literature with the next steps of looking at Kaiser Permanente (KP) to…Neurofilament light chain, tau-PET and microglia-PET predict clinical progression in amyloid-negative corticobasal syndrome
Objective: A head-to-head comparison of neuroimaging (tau-PET, microglia-PET, structural MRI) and plasma biomarker Neurofilament light chain (NfL) as prognostic tools for longitudinal clinical trajectories in…Women and PD: experienced changes in parkinson symptoms after menopause
Objective: This study aimed to gain insight into changes in parkinson (PD) symptoms experienced by women after menopause. Background: Although most people are diagnosed with…Understanding caffeine consumption in Huntington’s Disease
Objective: The purpose of this study is to better understand the amount of caffeine consumption in people with HD and the subjective motivations and consequences…Subthalamic Nucleus Deep Brain Stimulation in GBA-associated Parkinson Disease: Cognitive and motor follow-up of two clinical cases
Objective: To report the long-term motor and cognitive outcome of two patients with GBA-associated Parkinson’s disease (PD) who underwent STN-DBS surgery. Background: Recent studies suggest…Pisa syndrome and botulinum toxin injection in paraspinal muscles ipsilateral to the bending side: a pilot study
Objective: Our study aimed at evaluating the clinical and electromyographical effects of botulinum toxin (BoNT) injections in patients with Pisa syndrome (PS) in Parkinson’s disease…Linking volume of tissue activated to neural oscillations in deep brain stimulation
Objective: Exploring the effect of deep brain stimulation (DBS) settings on neural oscillations in Parkinson’s disease (PD) patients with subthalamic nucleus (STN) DBS and their…Early versus late levodopa administration in Parkinson’s disease: Comparative study
Objective: To evaluate levodopa-sparing strategy in terms of motor decline and complications. Background: Levodopa remains the gold standard for treatment of Parkinson’s disease(PD), as it…Melatonin for huntington disease (HD) gene carriers with HD-related sleep disturbance – a pilot study
Objective: To evaluate the efficacy of exogenous melatonin in improving sleep quality in Huntington disease (HD) gene carriers. Background: Various sleep disorders have been identified…The Quebec Parkinson Network (QPN): Interdisciplinary Collaboration in Parkinson’s Disease and Related Disorders Research.
Objective: By creating a participant registry, gathering information on participants, and ensuring appropriate data exchange with research groups, the QPN's primary goal is to increase…
- « Previous Page
- 1
- …
- 174
- 175
- 176
- 177
- 178
- …
- 186
- Next Page »